Cargando…

Prognostic role of podocalyxin-like protein expression in various cancers: A systematic review and meta-analysis

Several studies were conducted to explore the prognostic significance of podocalyxin-like protein (PODXL) expression in various cancers, with contradictory. This study aims to summarize the prognostic significance of PODXL expression in cancers. PubMed, the Cochrane Library and Embase were completel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jing, Zhao, Yongzhao, Qi, Ruizhao, Zhu, Xiaoning, Huang, Chenshen, Cheng, Sijin, Wang, Shengzhi, Qi, Xiaolong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581042/ https://www.ncbi.nlm.nih.gov/pubmed/28881743 http://dx.doi.org/10.18632/oncotarget.14199

Ejemplares similares

Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis
por: Zhao, Yongzhao, et al.
Publicado: (2017)

Prognostic and clinicopathological value of SIRT3 expression in various cancers: a systematic review and meta-analysis
por: Zhou, Yongping, et al.
Publicado: (2018)

Podocalyxin as a Prognostic Marker in Gastric Cancer
por: Laitinen, Alli, et al.
Publicado: (2015)

Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma
por: Heby, Margareta, et al.
Publicado: (2015)

Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma
por: Borg, David, et al.
Publicado: (2016)

Role of podocalyxin in astrocytoma: Clinicopathological and in vitro evidence
por: HUANG, TIANXIANG, et al.
Publicado: (2013)

Podocalyxin in Normal Tissue and Epithelial Cancer
por: Le Tran, Ngoc, et al.
Publicado: (2021)

Identification of LEA, a podocalyxin‐like glycoprotein, as a predictor for the progression of colorectal cancer
por: Yuan, Dezheng, et al.
Publicado: (2018)

Podocalyxin-Like Protein 1 Regulates TAZ Signaling and Stemness Properties in Colon Cancer
por: Lee, Wen-Ying, et al.
Publicado: (2017)

Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer
por: Larsson, A, et al.
Publicado: (2011)

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
por: Larsson, Anna, et al.
Publicado: (2012)

Podocalyxin‐Like Protein 1 Regulates Pluripotency through the Cholesterol Biosynthesis Pathway
por: Chen, Wei‐Ju, et al.
Publicado: (2022)

Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study
por: Boman, Karolina, et al.
Publicado: (2017)

Prognostic value of platelet-to-lymphocyte ratio in pancreatic cancer: a comprehensive meta-analysis of 17 cohort studies
por: Zhou, Yongping, et al.
Publicado: (2018)

Podocalyxin-Like Protein Is Expressed in Glioblastoma Multiforme Stem-Like Cells and Is Associated with Poor Outcome
por: Binder, Zev A., et al.
Publicado: (2013)

Podocalyxin regulates pronephric glomerular development in zebrafish
por: Ichimura, Koichiro, et al.
Publicado: (2013)

Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer
por: Larsson, Anna H., et al.
Publicado: (2016)

Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin
por: Hara, M., et al.
Publicado: (2012)

Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases
por: Larsson, Anna H, et al.
Publicado: (2013)

Involvement of Platelet–Tumor Cell Interaction in Immune Evasion. Potential Role of Podocalyxin-Like Protein 1
por: Amo, Laura, et al.
Publicado: (2014)

Podocalyxin regulates astrocytoma cell invasion and survival against temozolomide
por: WU, HAO, et al.
Publicado: (2013)

Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer
por: Eurola, Annika, et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte Ratio Is a Potential Prognostic Biomarker in Patients with Ovarian Cancer: A Meta-Analysis
por: Chen, Shubo, et al.
Publicado: (2017)

Podocalyxin is a marker of poor prognosis in colorectal cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014)

Urinary Podocalyxin as a Biomarker to Diagnose Membranous Nephropathy
por: Imaizumi, Takahiro, et al.
Publicado: (2016)

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer
por: Boman, K, et al.
Publicado: (2013)

Comparative effectiveness of combined therapy inhibiting EGFR and VEGF pathways in patients with advanced non-small-cell lung cancer: a meta-analysis of 16 phase II/III randomized trials
por: Zhao, Yongzhao, et al.
Publicado: (2016)

Podocalyxin‐like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin
por: Taniuchi, Keisuke, et al.
Publicado: (2016)

Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
por: Borg, David, et al.
Publicado: (2018)

Diminished Thrombogenic Responses by Deletion of the Podocalyxin Gene in Mouse Megakaryocytes
por: Pericacho, Miguel, et al.
Publicado: (2011)

Requirement of Podocalyxin in TGF-Beta Induced Epithelial Mesenchymal Transition
por: Meng, Xiaobo, et al.
Publicado: (2011)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

Early decrease in the podocalyxin to synaptopodin ratio in urinary Fabry podocytes
por: Trimarchi, Hernán, et al.
Publicado: (2018)

Emerging Role of Podocalyxin in the Progression of Mature B-Cell Non-Hodgkin Lymphoma
por: Tamayo-Orbegozo, Estíbaliz, et al.
Publicado: (2020)

Polo-like kinase 1 as a potential therapeutic target and prognostic factor for various human malignancies: A systematic review and meta-analysis
por: Wang, Ming-Wen, et al.
Publicado: (2022)

Prognostic Value of MicroRNA-497 in Various Cancers: A Systematic Review and Meta-Analysis
por: Liu, Zhiqiang, et al.
Publicado: (2019)

Identification of Podocalyxin-like Protein as a High Endothelial Venule Ligand for L-selectin: Parallels to CD34
por: Sassetti, Christopher, et al.
Publicado: (1998)

Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas
por: Heby, Margareta, et al.
Publicado: (2020)

Identification and characterization of podocalyxin--the major sialoprotein of the renal glomerular epithelial cell
Publicado: (1984)

The cell surface mucin podocalyxin regulates collective breast tumor budding
por: Graves, Marcia L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7mv1bvuqok2f70bmiu85oat741